SCHEMBL12415519

SCHEMBL12415519

CC(=O)OC[C@H]1O[C@@H](n2cnc(N)nc2=O)C(O)C1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.69
▸ DNMT1 P26358 2/20 0.69
▸ ALDH1A1 P00352 2/20 0.69
▸ TP53 P04637 2/20 0.69
▸ MTOR P42345 2/20 0.69
▸ GMNN O75496 1/20 0.69
▸ NFKB1 P19838 1/20 0.69
▸ THPO P40225 1/20 0.69
▸ HTT P42858 1/20 0.69
▸ RAB9A P51151 1/20 0.69
▸ BLM P54132 1/20 0.69
▸ HBB P68871 1/20 0.69
▸ PMP22 Q01453 1/20 0.69
▸ HINT1 P49773 3/20 0.52
▸ FBP1 P09467 1/20 0.46
▸ ATIC P31939 1/20 0.46
▸ ADRB1 P08588 1/20 0.46
▸ PNP P00491 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ GSK3A P49840 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15689915 1.00 LMNA (0.69) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL11794055 0.90 LMNA (0.58) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL6369753 0.89 DNMT1 (0.66) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL19888757 0.86 DNMT1 (0.72) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL15689845 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL19059876 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL13243124 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL1847445 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL21835519 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR
SCHEMBL13019177 0.85 LMNA (0.61) LMNADNMT1ALDH1A1TP53MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201800-A1 AZACITIDINE PROCESS AND POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2011-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201800-A1 AZACITIDINE PROCESS AND POLYMORPHS AZI2, DNMT3A, DCTD LMNA 1979/4885DNMT1 4/4885ALDH1A1 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback